Difficulties and Countermeasures of Prescription Indication Reviews of Chinese Patent Medicines
10.3870/j.issn.1004-0781.2024.03.010
- VernacularTitle:中成药适应证点评难点与对策
- Author:
Wenhao WEI
1
;
Chou MO
;
Ying HE
Author Information
1. 天津中医药大学第二附属医院药学部,天津 300250
- Keywords:
Chinese patent medicine;
Indications;
Prescription reviews;
Difficulties and countermeasures
- From:
Herald of Medicine
2024;43(3):390-393
- CountryChina
- Language:Chinese
-
Abstract:
Prescription indication reviews are the problematic points in reviewing prescriptions of Chinese patent medi-cines.However,there is no commonly recognized review standard.This article conducted a statistical analysis of the prescriptions reviewed by pharmacists from July to December 2022 in the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine.Combined with work experience,we analyzed the results and reasons for unqualified indication reviews,combed out the difficulties of the indications review in Chinese patent medicines,and proposed feasible strategies to provide support for the stand-ardization and standardized development in reviewing prescriptions of Chinese patent medicines.
